Skip to content
Strength & muscleEvidence review3 min read

Resistance training and BDNF in multiple sclerosis: small rise, low-certainty evidence

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Is resistance training effective to increase BDNF in multiple sclerosis? An updated systematic review and meta-analysis of isolated interventions. · PloS one · 2026 · Original paper ↗

Key takeaway

Pooling 4 controlled studies of 126 people with multiple sclerosis, isolated resistance training was linked to higher blood BDNF (SMD 0.49, 95% CI 0.15-0.83, p < 0.005). Certainty of evidence was low, and the 4 studies differed in design, so this should be read as a preliminary signal.

Study design

Evidence review

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Brain-derived neurotrophic factor (BDNF) supports neuroplasticity and has been linked to progression of multiple sclerosis (MS). Aerobic exercise is consistently tied to BDNF, but earlier reviews mixed several kinds of exercise, so the role of resistance training alone is unclear. The authors pooled controlled studies of isolated resistance training and peripheral BDNF in people with MS.

Who and how

Systematic review and meta-analysis (PROSPERO CRD420251141069). Six databases (PubMed, Web of Science, Scielo, Scopus, PEDro, Cochrane) were searched up to January 10, 2026. Controlled experimental studies of isolated resistance training with BDNF outcomes were included. Risk of bias used RoB 2.0 and ROBINS-I, and certainty used GRADE. A random-effects model pooled effects, with a Hartung-Knapp adjustment because there were few studies.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    4 studies (three randomized trials and one controlled non-randomized trial; 126 people with MS) were included. Interventions lasted 8-24 weeks, with 2-3 sessions per week.
  2. 2
    The pooled effect on peripheral BDNF was positive: SMD 0.49 (95% CI 0.15-0.83; Z = 2.80; p < 0.005), with no heterogeneity (I2 = 0%).
  3. 3
    With the Hartung-Knapp adjustment, the estimate was SMD 0.49 (95% CI 0.42-0.56; p = 0.0339).
  4. 4
    Two studies using low-to-moderate intensity training (Pilates-based and low-load with bands or weights) showed significant serum BDNF increases after 8 weeks, while studies with higher loads (about 80% of one-repetition maximum) showed no significant BDNF changes despite functional gains.

Limits & uncertainty

  1. 1
    Overall certainty of evidence was low because of risk of bias, inconsistency and imprecision.
  2. 2
    Only 4 studies and 126 participants were pooled, one of them non-randomized, so the result could change with new trials.
  3. 3
    The intensity pattern (benefit with low-to-moderate, none with high loads) comes from comparing a few studies and is not tested directly.
  4. 4
    BDNF is a blood marker, and the abstract does not show that a higher level means better MS outcomes such as disability or relapses.

What to take from it

For people with MS, this hints that regular, lower-intensity resistance training could raise BDNF, but the evidence is weak and BDNF is only a marker. It does not show a clinical benefit by itself. A program for MS should be planned with a neurologist or physiotherapist.

Reading your own data

BDNF can only be measured by a blood test, not by a wearable. What you can track is training itself: sessions per week, load and how hard it felt, plus fatigue and sleep from your tracker. Compare your own weeks on the same device and routine, not single sessions.

How to read this evidence

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Brain-derived neurotrophic factor (BDNF) is a key mediator of neuroplasticity and has been associated with disease progression in multiple sclerosis (MS). While aerobic exercise is consistently linked to BDNF modulation, the specific contribution of isolated resistance training (RT) remains unclear, as previous reviews have largely combined multimodal exercise interventions.

Objective

To systematically review and meta-analyze the effects of isolated RT on peripheral BDNF levels in individuals with MS (PROSPERO: CRD420251141069).

Methods

Searches were conducted in PubMed, Web of Science, Scielo, Scopus, PEDro and Cochrane up to January 10, 2026, using PICOT criteria. Controlled experimental studies investigating isolated RT and BDNF outcomes were included. Risk of bias was assessed using RoB 2.0 and ROBINS-I, and certainty of evidence was evaluated using GRADE. Due to methodological heterogeneity, a random-effects model was applied to estimate pooled effects.

Results

Four studies (three RCTs and one controlled non-randomized trial), totaling 126 participants with MS, were included. Interventions lasted 8-24 weeks, with training frequencies of 2-3 sessions per week. Meta-analytic synthesis revealed positive pooled effects (SMD = 0.49; 95%CI: 0.15 to 0.83; Z = 2.80; p < 0.005; I2 = 0%; Q = 1.681) with wide confidence intervals without crossing zero. With the Hartung-Knapp adjustment, due to the reduced number of studies, the analysis continued to show a positive intervention effect: (SMD = 0.49; 95%CI: 0.42 to 0.56; t = 3.716; p = 0.0339). Two studies using low-to-moderate intensity protocols (Pilates-based RT and low-load RT with bands/weights) showed significant increases in serum BDNF after 8 weeks. In contrast, studies employing higher loads (≈80% of one-repetition maximum: 1RM) demonstrated no significant BDNF changes despite functional gains. Overall certainty of evidence was rated as low due to risk of bias, inconsistency, and imprecision.

Conclusion

Isolated RT may increase peripheral BDNF levels in individuals with MS, but this effect is supported by limited and low-certainty evidence. Furthermore, given that only four studies were included in the meta-analysis, we suggest interpreting the results with some caution.

Sources & attribution

Is resistance training effective to increase BDNF in multiple sclerosis? An updated systematic review and meta-analysis of isolated interventions.

Pedon WR, Costa GCT, Cortizo Vidal LÁR, Inacio PA, Sales MM, Martins IM, Fajemiroye JO, Machado S, Aprigliano V, Inacio GR, Cameia AM, Chiappa GR, Portugal EDMM, Sá Filho AS.

PloS one · 2026-10-27

DOI: 10.1371/journal.pone.0359019 ↗PubMed · 42945167 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Overview of reviews

ACSM review of 137 reviews: resistance training works, and few programme details matter

The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.

Medicine & Science in Sports & Exercise

In-depth explainersRead study →
·Trial meta-analysis

Nearly every resistance training plan beat no exercise; heavy loads led for strength

In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.

British Journal of Sports Medicine

In-depth explainersRead study →
·Observational meta-analysis

Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes

Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.

British Journal of Sports Medicine

In-depth explainersRead study →
·Trial meta-analysis

Protein supplements and weight training: small extra gains, smaller in older adults

Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.

British Journal of Sports Medicine

In-depth explainersRead study →
Strength & muscle →